India Opens 5 Anti-Dumping Probes as Chinese Imports Face Fresh Scrutiny

India has opened five fresh anti-dumping investigations covering products imported from China, adding chemicals, pharmaceutical inputs, industrial equipment and copper tubes to a growing list of goods facing trade-remedy scrutiny. The investigations were initiated by the Directorate General of Trade Remedies (DGTR), the Commerce Ministry’s trade-defence arm, following complaints from domestic manufacturers that imported products were being sold at dumped prices and were causing or threatening injury to Indian producers.

The five investigations cover persulphates; clavulanic acid and its amine salt; certain counterbalance forklifts; internally grooved copper tubes and pipes; and caprolactam. China is included in every investigation, although several cases also cover imports from other countries. The probes do not mean anti-dumping duties have already been imposed: DGTR must investigate the allegations and establish dumping, injury and a causal link before recommending a remedy.

Key takeaways

• DGTR has launched five new anti-dumping investigations.
• Chinese imports are covered in all five cases.
• The products span chemicals, pharmaceuticals, industrial equipment and copper tubes.
• The persulphates probe covers China alone.
• Clavulanic acid is being investigated for imports from China and the European Union.
• Counterbalance forklifts from China and Japan are under investigation.
• Internally grooved copper tubes and pipes from China, Thailand and Vietnam face both anti-dumping and separate anti-subsidy scrutiny.
• Caprolactam imports from China, Russia, Thailand and the US are under investigation.
• DGTR has cited prima facie evidence of dumping and injury in several cases.
• Any eventual anti-dumping duty would require a separate decision by the Finance Ministry.
• The action comes as India’s merchandise trade deficit with China has reached a record level.

Five products are now under investigation

The latest DGTR action covers a surprisingly diverse set of products.

Product	Countries covered	Main use
Persulphates	China	Textile and chemical industries
Clavulanic acid and amine salt	China, EU	Pharmaceutical antibiotics
Counterbalance forklifts	China, Japan	Warehousing and industrial handling
Internally grooved copper tubes and pipes	China, Thailand, Vietnam	Industrial and heat-exchange applications
Caprolactam	China, Russia, Thailand, US	Nylon-6 and textile applications

DGTR’s official records show that the investigations were initiated on September 29 and 30, 2026 and remain ongoing.

The diversity of the cases is significant.

These are not five variations of the same industry problem. They involve different supply chains, different domestic manufacturers and different end markets.

What connects them is the allegation that imported products are entering India at prices that may be unfairly low relative to their normal value and are harming domestic producers.

What is anti-dumping?

Anti-dumping action is a trade-remedy mechanism used when imported goods are allegedly sold in an overseas market below their normal value and that pricing causes material injury to the domestic industry.

The process is different from a conventional import restriction.

A government cannot simply impose an anti-dumping duty because a product is cheap.

Investigators have to establish the relevant economic conditions, including the existence of dumping, the degree of dumping, injury to domestic producers and a causal connection between the dumped imports and that injury.

That distinction is particularly important in the current cases.

DGTR has started investigations. It has not declared all five products to have been dumped or ordered duties on them.

Persulphates: DGTR sees significant dumping margin

Persulphates are among the chemicals now facing the closest scrutiny.

The category includes ammonium, potassium and sodium persulphates, which are used as initiators and oxidising agents in textile and chemical applications.

According to DGTR findings cited by ANI, the authority found prima facie evidence that imports from China were being dumped in India. It also said the dumping margin appeared to be above the de-minimis level and significant.

The authority further found that imports had increased while prices declined, resulting in price undercutting and price suppression for domestic producers.

That combination is important.

A rise in imports alone does not establish dumping.

A fall in import prices alone does not establish injury.

But if investigators find evidence of dumped imports alongside rising volumes and declining domestic prices, the case for a trade-remedy investigation becomes stronger.

DGTR has therefore moved the matter into a formal investigation rather than treating the domestic industry’s complaint as insufficient.

Clavulanic acid: a pharmaceutical supply-chain issue

The second investigation covers clavulanic acid, also known as potassium clavulanate, and its amine salt.

Clavulanic acid is an active pharmaceutical ingredient used with penicillin-class antibiotics.

The investigation covers imports from China and the European Union.

This case has an additional strategic dimension because pharmaceutical ingredients sit upstream of finished medicines.

India has a large generic-drug manufacturing industry, but it remains dependent on imports for several active pharmaceutical ingredients and chemical intermediates.

If a domestic producer argues that imported material is being sold below fair value and is preventing local manufacturing capacity from developing, an anti-dumping investigation can become part of a broader effort to strengthen domestic supply.

DGTR has said there is prima facie evidence that the alleged dumping has caused material retardation to the establishment of the domestic industry.

In other words, the concern is not necessarily limited to existing production losses. The investigation can also examine whether unfair import competition is preventing a domestic industry from becoming established.

Forklifts: industrial equipment comes under scrutiny

The third case concerns certain counterbalance forklifts imported from China and Japan.

Forklifts are central to warehouses, factories, distribution centres and logistics operations.

The product is therefore closely connected to India’s industrial and e-commerce infrastructure.

DGTR said imports had increased and landed prices remained below the domestic industry’s selling price, creating price undercutting.

The authority found sufficient prima facie evidence of material injury to domestic producers to justify launching the investigation.

The presence of Japan alongside China is also notable.

It shows that the latest action is not automatically a China-only exercise. Where domestic manufacturers allege unfair import pricing from multiple countries, the investigation can cover all relevant sources.

China happens to appear in every one of the five cases because of the products and complaints currently before DGTR.

Copper tubes face both dumping and subsidy scrutiny

Internally grooved copper tubes and pipes represent one of the more complicated cases.

The anti-dumping investigation covers China, Thailand and Vietnam.

Separately, DGTR has initiated a countervailing-duty, or anti-subsidy, investigation covering the same product and countries.

The distinction matters.

An anti-dumping investigation asks whether exporters are selling goods in India at dumped prices.

A countervailing investigation examines whether foreign government subsidies are benefiting exporters and causing injury to the domestic industry.

Running both investigations indicates that authorities are examining more than one possible source of distortion in the market.

For manufacturers using copper tubes in industrial equipment, cooling systems and related applications, the outcome could affect procurement costs.

For domestic producers, however, trade remedies could provide greater pricing room if the investigations ultimately result in duties.

Caprolactam links chemicals to the textile industry

The fifth case covers caprolactam imports from China, Russia, Thailand and the United States.

Caprolactam is a key raw material used to manufacture Nylon-6.

Nylon-6 is then used in products including nylon filament yarn and nylon tyre cord fabric.

This makes the investigation relevant well beyond the chemical industry.

Any significant change in the cost or availability of caprolactam can potentially affect downstream textile and industrial-material manufacturers.

DGTR said import volumes had increased despite a decline in domestic demand, while landed prices were below the applicant’s selling price.

The authority found sufficient prima facie evidence of dumping, injury and a causal link to justify the investigation.

Why China appears in every case

The common China link is economically significant.

China is India’s largest source of merchandise imports, and the two countries have a large and persistent trade imbalance.

According to data cited by PTI, India’s imports from China increased 16% to $131.63 billion in FY2025-26, while exports to China rose 36.66% to $19.47 billion.

That produced a record merchandise trade deficit of approximately $112.6 billion with China, compared with $99.2 billion the previous year.

The latest DGTR investigations therefore arrive against a much broader trade backdrop.

India is not merely examining individual products.

It is increasingly scrutinising areas where rapid import growth, low prices or foreign subsidies could undermine domestic manufacturing.

India’s trade-defence activity is broadening

The five cases are part of a wider wave of trade-remedy activity.

DGTR’s official database currently lists ongoing investigations involving products ranging from sodium cyanide and pharmaceutical intermediates to industrial chemicals, metals and machinery.

The authority has also been examining countervailing-duty cases in addition to anti-dumping investigations.

Recent cases include investigations into melamine from China, 4-aminodiphenylamine from China and the European Union, and several pharmaceutical chemicals from China.

The pattern suggests that trade defence is becoming a more active component of India’s industrial policy rather than an occasional response to individual import disputes.

This is not yet a new tariff wall

The wording around the latest action is important.

India has opened investigations, not imposed five new anti-dumping duties.

There is a substantial difference between the two.

During an investigation, exporters, importers and domestic producers can submit information and arguments. DGTR examines pricing, import volumes, domestic prices, financial performance and other evidence before reaching its findings.

If DGTR ultimately recommends an anti-dumping duty, the Finance Ministry takes the final decision on whether to impose it.

Therefore, companies importing these products should not assume that the current investigations automatically translate into higher customs costs.

The final outcome could be a duty, a different remedy or no duty if the required conditions are not established.

Domestic manufacturers are seeking protection

The latest cases were initiated following complaints from domestic manufacturers.

That tells investors and businesses something important about the competitive pressures being experienced on the ground.

Domestic producers typically seek anti-dumping investigations when they believe imported products are affecting their sales, prices, capacity utilisation or profitability.

The trade-remedy system gives them a formal route to present that evidence.

But the system is not designed simply to protect companies from competition.

The investigation must establish that the competition is occurring under conditions that qualify as dumping and that the resulting injury is material.

That makes the evidence gathered during the investigation more important than the initial complaint.

Potential benefits for Indian manufacturers

If duties are eventually imposed, domestic producers could gain some pricing protection.

The immediate benefit would be reduced pressure from imports that are found to be unfairly priced.

That could help manufacturers improve capacity utilisation and margins.

In strategic industries, it could also support additional investment.

For example, pharmaceutical-ingredient producers may have greater incentive to expand local capacity if imported alternatives are no longer able to undercut them to the same extent.

Chemical manufacturers could similarly use improved market economics to invest in plants and technology.

However, the benefits are not cost-free.

Downstream industries could face higher input costs

Anti-dumping duties can protect one industry while raising costs for another.

This is the central policy trade-off.

A domestic manufacturer of caprolactam may benefit from reduced import competition.

But a downstream Nylon-6 producer could face higher input costs if cheaper imports become less available.

The same issue can arise with copper tubes.

Domestic tube producers may gain from protection, while manufacturers that use those tubes in cooling, industrial or other equipment may have to pay more.

The ideal trade-remedy outcome is therefore not simply the highest possible duty.

It is a remedy that addresses unfair trade without unnecessarily damaging downstream industries that rely on imports.

Why the action matters for India’s manufacturing strategy

India has spent years attempting to increase domestic manufacturing and reduce excessive dependence on imported industrial inputs.

Production-linked incentives, electronics manufacturing programmes and supply-chain policies have all been designed around this objective.

Trade remedies operate alongside those policies.

An incentive can make domestic production more competitive.

An anti-dumping measure can prevent an imported product from being sold at a price that domestic manufacturers argue is artificially depressed.

Together, these policies can create a more favourable environment for local production.

But excessive protection can also make domestic industries dependent on tariffs rather than productivity.

The long-term objective therefore has to be competitive manufacturing, not permanent protection.

China’s industrial overcapacity adds pressure

The latest investigations also come at a time when governments around the world are increasingly focused on China’s industrial capacity and export flows.

China has enormous manufacturing capacity across chemicals, metals, machinery and intermediate goods.

When domestic demand is weaker than expected, excess production can be redirected toward export markets.

That can place pressure on producers in importing countries.

The concern is particularly strong in industries where products are relatively standardised and price competition is intense.

India’s latest actions therefore fit into a wider global trend of governments scrutinising Chinese industrial exports.

The WTO framework matters

Anti-dumping duties are not inherently inconsistent with global trade rules.

The World Trade Organization permits members to use trade-remedy measures when the relevant conditions are established and prescribed procedures are followed.

That is why India’s DGTR conducts detailed investigations rather than simply banning imports.

The objective is to determine whether the alleged trade distortion exists and, if so, what remedy is necessary to address the injury.

This also gives foreign exporters an opportunity to defend their position.

The process is therefore intended to be evidence-driven rather than purely political.

What happens next?

The next phase will involve evidence gathering.

DGTR will examine submissions from domestic producers, foreign exporters and importers.

Investigators will assess import volumes, pricing, normal value, dumping margins, domestic-industry performance and the relationship between imports and any claimed injury.

For the copper-tube case, the parallel anti-subsidy investigation will examine whether government support in the exporting countries contributed to the alleged injury.

Only after completing this process can DGTR make its final recommendations.

The Finance Ministry then decides whether to impose any recommended duty.

What businesses should watch

For Indian manufacturers, the investigations could become an important pricing and capacity signal.

If preliminary or final findings confirm significant dumping, companies competing directly with the imports could see improved pricing conditions.

For importers and downstream manufacturers, the risk is different.

They need to monitor whether duties are eventually recommended and whether alternative suppliers can replace the affected imports.

Companies relying heavily on China for critical industrial inputs may also begin reassessing supply-chain concentration.

That could lead to greater sourcing from Japan, South Korea, Southeast Asia, Europe or domestic suppliers where economically viable.

The Bigger Picture

India’s latest five anti-dumping investigations show that trade policy is becoming increasingly intertwined with its manufacturing strategy. The government is simultaneously trying to attract investment, expand domestic capacity and ensure that imported products do not undermine local producers through pricing practices that meet the legal definition of dumping.

The fact that China appears in every one of the five cases is significant, but it should not be interpreted as evidence that India has already concluded that Chinese exporters violated trade rules. Each case remains under investigation, and several also include other countries. The process is designed to establish whether dumping occurred, whether domestic industry suffered material injury and whether the two are causally connected.

The more important long-term question is what happens after the investigations. If trade remedies are used selectively alongside productivity improvements and investment, they can help Indian manufacturers scale. If protection becomes permanent without improving competitiveness, downstream industries and consumers could eventually bear higher costs.

Looking Ahead

The five investigations will now move through DGTR’s evidence-gathering and assessment process. The most important developments will be preliminary or final findings that establish whether dumping and injury actually occurred. Until those findings are issued, there is no basis to treat the cases as confirmed violations or assume that duties will definitely follow.

For India’s broader China strategy, the cases underline a growing willingness to use trade-defence instruments alongside industrial policy. With the bilateral trade deficit reaching a record $112.6 billion in FY2025-26, pressure to strengthen domestic manufacturing will remain high. The challenge for policymakers will be to protect viable Indian production without making critical industrial inputs unnecessarily expensive for the companies that depend on them.